Xcelerating the growth, success and full potential of MedTech development and Healthcare Delivery with End to End control.
Xcelerate seeks to acquire rather than develop its technology / healthcare delivery. We understand that engineering advancements in non-medical fields often have unrealized applications in medical technology & clinical care and the silos existing between advanced engineering and medicine have been poorly bridged. Xcelerate is unique in that it was designed from inception to span the divide between initial non-medical engineering advancements and its application to clinical care.
Our 3-pillar model is gaining momentum! We've secured non-dilutive funding to accelerate growth for ESN Group— stay tuned for exciting developments!
Read More:
#growth #OTCQB
$XCRT Launch of the Ceramedx Tik Tok Skincare Campaign started on October 30th following a successful Ceramedx promotion in early October targeting the Army & Air Force Exchange Membership.
Read more:
$XCRT Today we announced the commencement of the nationalization process for our two PCT international patent applications:
PCT/US2023/015755 & PCT/US2023/016194.
Read more:
